Antiplatelet agent stroke discharge prescribe type

General Details:

Name:
Antiplatelet agent stroke discharge prescribe type
Steward:
NINDS
Definition:
Type(s) of antiplatelet agents prescribed at discharge following stroke
Registration Status:
Qualified

Permissible Values:

Data Type:
Value List
Unit of Measure:
Ids:
Value Code Name Code Code System Code Description
Aspirin Aspirin Aspirin
Aspirin/Dipyridamole (in separate formulations or as Aggrenox) Aspirin/Dipyridamole (in separate formulations or as Aggrenox) Aspirin/Dipyridamole (in separate formulations or as Aggrenox)
Clopidogrel (Plavix) Clopidogrel (Plavix) Clopidogrel (Plavix)
Cilostazol Cilostazol Cilostazol
Other, specify Other, specify Other, specify

Designations:

Designation:
Antiplatelet agent stroke discharge prescribe type
Tags:

Designations:

Definition:
Type(s) of antiplatelet agents prescribed at discharge following stroke
Tags:

Reference Documents:

ID:
Title:
URI:
Provider Org:
Language Code:
Document:
Barnes GD, Ageno W, Ansell J, Kaatz S; Subcommittee on the Control of Anticoagulation of the International Society on Thrombosis and Haemostasis. Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH [published correction appears in J Thromb Haemost. 2015;13(8):1539]. J Thromb Haemost. 2015;13(6):1154-1156.<br /><br />Kim BJ, Kwon SU, Park JH, Kim YJ, Hong KS, Wong LKS, Yu S, Hwang YH, Lee JS, Lee J, Rha JH, Heo SH, Ahn SH, Seo WK, Park JM, Lee JH, Kwon JH, Sohn SI, Jung JM, Navarro JC, Kim HY, Kim EG, Kim S, Cha JK, Park MS, Nam HS, Kang DW; PICASSO Investigators. Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage: Subgroup Analysis of the PICASSO Trial. Stroke. 2020 Mar;51(3):931-937.

Identifiers:

Source:
NLM
Id:
NET_eGSd9w
Version:
Source:
NINDS
Id:
C58952
Version:
1
Source:
BRICS Variable Name
Id:
AntiplatAgStrkDischrgPrscrbTyp
Version: